Bristol-Myers Squibb
Headquartered in New York, Bristol-Myers Squibb is a member of the Fortune 250 operating in the Pharmaceuticals Biotechnology and Life Sciences industry. Chris Boerner, Ph.D. and Giovanni Caforio, MD serve as CEO/President and Chairman, respectively, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $180,751 to Republican causes and $173,336 to Democratic causes. Under their tenure, Bristol-Myers Squibb currently holds a ‘High’ rating.
Company Leadership
Chris Boerner, Ph.D.
Chris Boerner currently holds the position of Chief Executive Officer at Bristol Myers Squibb, based in New York, New York, with a tenure of 8 years with the company. Boerner previously served on the Board of Directors at Achaogen and served in various roles at Seattle Genetics, Genentech, and McKinsey & Co.
In addition to his corporate responsibilities, Dr. Boerner is involved in non-profit initiatives, contributing to Capital Health and Liberty Science Center. He holds a B.A. from Washington University in St. Louis and a Ph.D. from the University of California Berkeley.
Giovanni Caforio, MD
Giovanni Caforio, MD, currently holds the position of Executive Board Chair at Bristol-Myers Squibb, previously serving as the CEO, with a tenure of 23 years with the company. Caforio currently sits on the Board of Directors at Stryker and previously served in various executive positions at Abbott Laboratories.
In addition to his corporate responsibilities, Dr. Caforio is actively involved in non-profit initiatives, contributing to Pharmaceutical Research and Manufacturers of America, the CEO Roundtable on Cancer, and previously with Business Roundtable. He earned his M.D. from the University of Rome, Italy.
Dr. Caforio has contributed $130,600 in political giving to the Republican party and $21,280 to the Democrat party.
Political Contributions of Leadership
Leadership
CEO
Chris Boerner, Ph.D.
Exec board Chairman
Giovanni Caforio, MD
Exec VP, Chief Commercialization Officer
Adam Lenkowsky
Exec VP, Chief HR Officer
Ann M. Powell
Sr. VP, Chief Compliance and Ethics Officer
Cari Gallman
Exec VP and CFO
David Elkins
Exec VP, Strategy and Business Development
Elizabeth A. Mily
Sr. VP, Global Medical Affairs
Estelle Vester-Blokland, MD
Exec VP, Chief Digital and Technology Officer
Greg Meyers
Exec VP, Global Product Development and Supply
Karin Shanahan
VP, Chief Diversity and Inclusion Officer
Pamela Fisher
Exec VP, Chief Medical Officer, Drug Development
Samit Hirawat, MD
Exec VP, General Counsel
Sandra Leung
Sr. VP, Chief of Staff to the CEO
Wendy Short Bartie
Board Member
Chris Boerner, PhD
Board Member
Deepak L. Bhatt, MD, MPH
Board Member
Gerald L. Storch
Board Member
Julia A. Haller, MD
Board Member
Karen H. Vousden, Ph.D.
Board Member
Manuel Hidalgo Medina, MD, Ph.D.
Board Member
Phyllis R. Yale
Board Member
Derica W. Rice